Investigating how certain receptors affect lung inflammation
Novel cysteinyl leukotriene receptor signaling in regulating cellular, and molecular events in lung inflammation
This study is looking at how certain molecules in the lungs affect inflammation and immune responses, especially in people with lung injuries or breathing problems, to help find better treatments for these conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Toledo Health Sci Campus NIH-funded |
| Lab location | 1 site (Toledo, United States) |
| Project ID | NIH-11094560 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of cysteinyl leukotrienes and their receptors in lung inflammation, particularly in conditions like acute lung injury and respiratory distress. The researchers will explore how these receptors influence the behavior of immune cells called macrophages, which play a crucial role in inflammation. By conducting experiments both in the lab and in animal models, they aim to uncover the mechanisms by which these receptors regulate inflammation and immune responses in the lungs. This could lead to new insights into treating respiratory conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults experiencing acute lung injury or respiratory distress syndromes.
Not a fit: Patients with chronic lung conditions unrelated to acute inflammation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for patients suffering from acute lung injuries and related respiratory conditions.
How similar studies have performed: Previous research has shown promising results in understanding the role of leukotriene receptors in inflammation, suggesting that this approach could yield valuable insights.
Where this research is happening
Toledo, United States
- University of Toledo Health Sci Campus — Toledo, United States (Active)
Researchers
- Principal investigator: Paruchuri, Sailaja — University of Toledo Health Sci Campus
- Study coordinator: Paruchuri, Sailaja
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.